Day: October 9, 2023

PASADENA, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage biotechnology company developing a novel class of cancer therapy called PP2A inhibitors, today announced the passing of its founder and Executive Chairman, John S. Kovach, M.D. Dr. Kovach, 87, founded the Company in 2005 and held a distinguished medical and scientific career that focused on the causation and treatment of cancer. Dr. Kovach served as LIXTE’s President and Chief Executive Officer from 2005 through September 26, 2023. In connection with the Company’s management succession plan, Dr. Kovach was succeeded as President and Chief Executive Officer by Bas van der Baan on that date. From 1994 through 2000, Dr. Kovach was Executive Vice President for Medical and Scientific...

PIC technology allows for repeatable production with flexible capacity increases ALHAMBRA, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) — EMCORE Corporation (Nasdaq: EMKR), the world’s largest independent provider of inertial navigation solutions to the aerospace and defense industry, announced today the advancement of Photonic Integrated Chip (PIC) technology and integration into all of the Company’s open-loop FOG-based products. PIC technology resulted from three years of development and began integration into EMCORE’s previous generation open-loop designs in late 2021 through 2022, culminating with the launch of the TAC-450 Inertial Measurement Unit (IMU), EMCORE’s first IMU series with PIC Inside™, and the new TAC-450 single- and multi-axis FOGs. The PIC enables significantly improved reliability, unit-to-unit repeatability,...

NEW YORK and TOKYO, Oct. 09, 2023 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Content Management System (“CMS”) platform was awarded as the top market share in sales value in Japan for eight consecutive years, according to ITR Corporation, an independent IT consulting and research firm. The report disclosed that HeartCore owns a leading 15% market share in Japan, with the second contender behind the Company at 11.7%. This achievement underscores the unwavering confidence that 680 Japanese companies have placed in HeartCore’s CMS as the primary platform for corporate content management. HeartCore continues to solidify its position as the leading CMS platform in Japan, and with the recent acquisition...

FORT LAUDERDALE, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) — Golden Grail Beverages (OTC: GOGY) is pleased to announce that it has expanded its distribution of Spider Energy Drink to the Grocery Supply Company. This partnership builds on Golden Grail’s Beverages successful collaboration with the Grocery Supply Company to distribute Sway Energy to convenience stores in several states, including Alabama, Arkansas, Georgia, Florida, Kansas, Louisiana, Oklahoma, Mississippi, Missouri, Nebraska, New Mexico, South Carolina, and Texas. Spider Energy Drink caters to the growing demand of consumers who want a highly caffeinated energy drink that offers the crispness of a carbonated beverage without the typical energy drink aftertaste. While Sway Energy Drink remains a favorite for consumers with its moderate 160 mg caffeine content per...

TN-301 Demonstrates Tolerability, Potential for Once Daily Dosing, Target Engagement and Selectivity for HDAC6 in Phase 1 Clinical Trial of Healthy Participants Combination of Tenaya’s HDAC6 inhibitors with Empagliflozin Shows Additive Benefits in Preclinical HFpEF Model and Highlights Differentiated Mechanism of Action SOUTH SAN FRANCISCO, Calif. and CLEVELAND, Oct. 09, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today released new data for TN-301 at the 2023 Heart Failure Society of America (HFSA) Annual Scientific Meeting. TN-301 is Tenaya’s highly selective small molecule inhibitor of histone deacetylase 6 (HDAC6) being developed for...

The Company Holds a US Patent for the Same Treatment FREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that it received a Taiwanese patent, Application No. 109130285, for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract, which is used in the Company’s asset ABV-1504 for the treatment of Major Depressive Disorder (MDD). The Company was previously awarded a U.S. patent, US 11,554,154 B2, on April 25, 2023, for the same treatment. “These patents grant ABVC the right to exclude others from using, offering, or selling PDC-1421, throughout the United States and Taiwan until the year...

Company to Discuss Upcoming Briquilimab Clinical Studies in Both Chronic Spontaneous Urticaria and Chronic Inducible Urticaria REDWOOD CITY, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), as well as lower to intermediate risk myelodysplastic syndromes (LR-MDS) and novel stem cell transplant conditioning regimens, today announced that it will host a KOL webinar on the potential of briquilimab in chronic urticaria on Wednesday, October 11, 2023 at 8:00 AM Eastern Standard Time. The event will feature Dr. Stephen Galli, Dr. Marcus Maurer, and Dr. Jeffrey...

NBA-themed Virtual Sports give basketball fans from around the world an opportunity to engage with archived footage featuring their favorite teams. NEW YORK, Oct. 09, 2023 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware and services, announced today that they have signed an agreement with the National Basketball Association (NBA) securing the rights to develop Virtual Sports games centered around the world’s premier professional basketball league’s archived footage. The NBA-themed Virtual Sports offerings will provide fans the ability to wager on teams in fast-paced matchups. Users will have many of the same wagering options as a standard sportsbook including money line bets, over/under total score, etc. The NBA-themed Virtual...